IGF2BP2 and ovarian carcinoma: In cancer, IMP2 serves as a pivotal player in multiple cancer types, including colorectal adenocarcinomas, breast adenocarcinomas, leukemia, lymphoma, hepatocellular carcinomas, lung adenocarcinomas, ovarian carcinomas, endometrial cancer, oral cancer, renal cell carcinoma, thyroid cancers, and glioblastoma.